<qa>  What is the tertiary objective of this study?A tertiary objective of this study will be to examine the effects of dramatically reducing low-density lipoproteins cholesterol in patients with diabetic macular edema and elevated serum lipids. Change in vision and change in retinal thickness will be compared across three groups; 1 patients who do not have elevated serum lipids at baseline, 2 patients who have elevated lipids at baseline and receive standard of care treatment, and 3 patients who have elevated lipids at baseline and are aggressively treated pharmacologically. This tertiary objective will be assessed for the feasibility of this randomization. 